The effect of inhibition of mitochondrial protein synthesis on the proliferation and phenotypic properties of a rat leukemia in different stages of in-vivo tumor development.
It has been shown before that prolonged treatment with doxycycline (DC), an inhibitor of mitochondrial protein synthesis, leads to proliferation arrest of a leukemia in the rat and, moreover, to eradication of this tumor. It has also been demonstrated that the period of treatment required to achieve this is shorter when DC administration is started in later stages of tumor progression. Therefore, the leukemic cells may have properties with regard to DC sensitivity which change with time during tumor progression. In the present study this hypothesis was tested by studying the permeability for DC, the presence of cell-surface molecules, and the mitochondrial content of the leukemic cells in various stages of tumor development in control and in DC-treated rats. Changes in DC permeability or antigenic phenotype were not observed, but the content of mitochondria decreases during tumor progression. DC treatment leads to an additional reduction of the content of functional mitochondria which results in proliferation arrest. The higher mitochondrial content of the leukemic cells during the earlier stages of tumor development explains thus why a longer period of DC treatment is needed to achieve growth arrest when treatment is started in these stages.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D004318:Doxycycline / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000378:metabolism*; D010539:Permeability; D010641:Phenotype; D014176:Protein Biosynthesis; D051381:Rats
D000951:Antigens, Neoplasm; D004318:Doxycycline